Literature DB >> 6514011

Inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by mexiletine and related compounds.

M Eriksson, C J Fowler.   

Abstract

The in vitro inhibition by mexiletine and related compounds of the activity of rat brain, heart and lung monoamine oxidase-A (MAO-A), rat brain MAO-B, human platelet-poor plasma benzylamine oxidase and a clorgyline-resistant, semicarbazide-sensitive amine oxidase (SSAO) distinct from both MAO and benzylamine oxidase has been studied. The compounds were most active towards MAO-A and SSAO. IC50 values for mexiletine towards rat heart MAO-A and SSAO were 10 mumol/l and 320 mumol/l, respectively. Replacement of the para-hydrogen atom in the mexiletine aromatic ring by bromine increased potency towards both MAO-A and SSAO. Replacement of the ortho-methyl group in the mexiletine aromatic ring by hydrogen increased the potency towards SSAO alone. FLA 1042, with both these substitutions, was found to be a reversible mixed-type inhibitor of both MAO-A (Kislopei 1.4 mumol/l, Kiinti 24 mumol/l) and of SSAO (Kislopei 12 mumol/l, Kiinti 6 mumol/l).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6514011     DOI: 10.1007/bf00506236

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  32 in total

1.  Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase.

Authors:  C H Donnelly; D L Murphy
Journal:  Biochem Pharmacol       Date:  1977-05-01       Impact factor: 5.858

2.  Some puzzling pharmacological effects of monoamine oxidase inhibitors.

Authors:  J Knoll; K Magyar
Journal:  Adv Biochem Psychopharmacol       Date:  1972

3.  Some factors influencing the metabolism of benzylamine by type A and B monoamine oxidase in rat heart and liver.

Authors:  D Parkinson; G A Lyles; B J Browne; B A Callingham
Journal:  J Pharm Pharmacol       Date:  1980-12       Impact factor: 3.765

4.  The deamination of monoamines by pig dental pulp.

Authors:  A Norqvist; C J Fowler; L Oreland
Journal:  Biochem Pharmacol       Date:  1981-03-01       Impact factor: 5.858

5.  Selective monoamine oxidase inhibitors. Compounds derived from phenethylamine and 1-phenoxy-2-aminopropane.

Authors:  Y Kumar; L Florvall; A L Ask; S B Ross; A C Holm; S O Ogren
Journal:  Acta Pharm Suec       Date:  1983

6.  A study of amine oxidases in bleomycin-induced pulmonary fibrosis.

Authors:  B E Hayes; D F Counts; J Kelley; D E Clarke
Journal:  Biochem Pharmacol       Date:  1983-08-01       Impact factor: 5.858

7.  A comparison of cardiac and vascular clorgyline-resistant amine oxidase and monoamine oxidase. Inhibition by amphetamine, mexiletine and other drugs.

Authors:  D E Clarke; G A Lyles; B A Callingham
Journal:  Biochem Pharmacol       Date:  1982-01-01       Impact factor: 5.858

8.  The effect of DSP-4 (N-[2-chloroethyl]-N-ethyl-2-bromobenzylamine) on monoamine oxidase activities in tissues of the rat.

Authors:  G A Lyles; B A Callingham
Journal:  J Pharm Pharmacol       Date:  1981-10       Impact factor: 3.765

9.  Stereoselective inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by 4-dimethylamino-2,alpha-dimethylphenethylamine (FLA 336).

Authors:  C J Fowler; M Eriksson; G Thorell; O Magnusson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-10       Impact factor: 3.000

10.  The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone.

Authors:  C J Fowler; M S Benedetti
Journal:  J Neurochem       Date:  1983-06       Impact factor: 5.372

View more
  2 in total

Review 1.  Semicarbazide-sensitive amine oxidase (SSAO) in the brain.

Authors:  Toshio Obata
Journal:  Neurochem Res       Date:  2002-04       Impact factor: 3.996

2.  Stereoselective inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by 4-dimethylamino-2,alpha-dimethylphenethylamine (FLA 336).

Authors:  C J Fowler; M Eriksson; G Thorell; O Magnusson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-10       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.